EUVIMEDEUVIMED entdecken
Crossref

Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20

Benjamin N Rome, Aayan N Patel, Aaron S Kesselheim

Health Affairs · 2023

DOI: 10.1377/hlthaff.2022.01029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Benjamin N Rome und 2 weiteren Autor:innen. Beteiligte Einrichtung: Benjamin N. Rome (brome@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University, Boston, Massachusetts. Hauptthemen laut MEDLINE: Medicaid, Prescription Drugs. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicaidPrescription DrugsAgedHumansUnited StatesMedicareDrugs, GenericDrug Costs

Substanzen

Drugs, GenericPrescription Drugs

Autor:innen und Institutionen

  • Benjamin N. Rome (brome@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University, Boston, Massachusetts.
  • Aayan N. Patel, Brigham and Women's Hospital and Harvard University.
  • Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard University.

Zitieren

APA

Rome, B. N., Patel, A. N., & Kesselheim, A. S. (2023). Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20. Health Affairs. https://doi.org/10.1377/hlthaff.2022.01029

Vancouver

Rome BN, Patel AN, Kesselheim AS. Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20. Health Affairs. 2023. doi:10.1377/hlthaff.2022.01029

BibTeX
@article{Rome2023,
  author = {Rome, Benjamin N and Patel, Aayan N and Kesselheim, Aaron S},
  title = {Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017–20},
  journal = {Health Affairs},
  year = {2023},
  doi = {10.1377/hlthaff.2022.01029}
}
Kostenlos starten →